Chinese biotech firm Binhui secures $93m Series C led by Temasek’s Vertex Ventures, others

Chinese biotech firm Binhui secures $93m Series C led by Temasek’s Vertex Ventures, others

Photo: Pixabay

Gene-focused biotechnology player Wuhan Binhui Biotech on Wednesday announced the completion of a 600 million yuan ($93 million) Series C round funding jointly led by healthcare-focussed Share Capital, Temasek’s Vertex Ventures China, Qianhai FOF, and CICC Capital’s sub-fund.

Returning investor Beijing Lapam Capital Management re-upped in the latest round, Binhui Biotech said in a WeChat post. Lapam had partnered Fortune Capital to seed 26.5 million yuan ($4 million) in Binhui in 2017. In 2018, Lapam exclusively poured 20 million yuan ($3 million) into the company.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter